JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 29 No. 2 147-158
© 1988 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jafri, R. A.
Right arrow Articles by Hawkins, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jafri, R. A.
Right arrow Articles by Hawkins, L. A.

Technetium-99m MAG3, a Comparison with Iodine-123 and Iodine-131 Orthoiodohippurate, in Patients with Renal Disorders

Rafaqat Ali Jafri, Keith E. Britton, Cyril C. Nimmon, Kishor Solanki, Adil Al-Nahhas, Jamshed Bomanji, Jurij Fettich and Laurie A. Hawkins

Department of Nuclear Medicine, St. Bartholomew's Hospital, London, United Kingdom

Correspondence: For reprints contact: K. E. Britton, MD, Dept. of Nuclear Medicine, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE UK.

ABSTRACT

A Phase I study in 12 patients with renal disorders compared the simultaneous clearances of 99mTc-labeled mercaptoacetyltriglycine (MAG3) and 131I-labeled orthoiodohippurate (OIH). The ratio of MAG3 to OIH clearance was 0.61 ± 0.08 as a result of its smaller volume of distribution, ratio 0.65 ± 0.09, for the clearance half-lives were similar, ratio 1.09 ± 0.12.A Phase II study performed serially in 20 patients with equal doses of [99mTc]MAG3 and [123I]OIH gave images of equal quality. The relative renal functions were highly correlated (r = 0.97, p < 0.001) and transit time analyses gave good correlations: parenchymal transit time index r = 0.81, p < 0.05. We conclude that [99mTc]MAG3 has some advantages over [99mTc]DTPA and is a suitable replacement for [123I]hippuran in routine renal imaging, relative function, and transit time studies, but not for the accurate estimation of the renal plasma flow.




This article has been cited by other articles:


Home page
J. Nucl. Med. Technol.Home page
M. P. Diaz, E. E. Aparicio, O. D. Rizo, R. R. Diaz, and C. H. Rodriguez
Administered Activity Optimization in 99mTc-MAG3 Renography for Adults
J. Nucl. Med. Technol., December 1, 2003; 31(4): 216 - 221.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Sitek, G. T. Gullberg, E. V.R. Di Bella, and A. Celler
Reconstruction of Dynamic Renal Tomographic Data Acquired by Slow Rotation
J. Nucl. Med., November 1, 2001; 42(11): 1704 - 1712.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1988 by the Society of Nuclear Medicine.